How much does Zepbound cost? With and without insurance

How much does Zepbound cost per month?

Anywhere from $25 to about $1,086 — and where you land depends almost entirely on your insurance, not your pharmacy. List price is roughly $1,086 a month, but list price is a number almost nobody actually pays: with a commercial plan that covers Zepbound, the savings card can cut it to $25; with no coverage at all, Lilly’s self-pay program runs about $349–$499.

Why is the spread so wide? US drug pricing stacks a sticker price on top of rebates, plan-by-plan negotiations, and manufacturer programs — so “what does Zepbound cost” has no single answer, only your answer. It comes down to three questions: what insurance you carry, whether that plan covers weight-loss medication, and which of Lilly’s programs you qualify for. The rest of this page walks each path.

Zepbound cost without insurance

If you’re paying cash, don’t walk the prescription into a regular pharmacy — that’s the ~$1,086 route. Lilly sells Zepbound directly to self-pay patients through LillyDirect, its online pharmacy channel, at a fraction of list.

Two formats:

• Single-dose vials — you draw the dose with a syringe instead of clicking a pen. Least expensive option, and the reason the program can undercut list price so hard.
• KwikPen — a multi-dose pen covering four weekly doses, sold through the same self-pay channel (⚠ verify current formats and strengths offered).

Pricing is tiered by dose: the lowest strength runs about $349 a month, and higher strengths about $499 (⚠ verify the exact per-dose tiers — they’ve shifted more than once). You still need a valid prescription; the difference is that no insurance is billed, no prior authorization is required, and no savings card is involved. Note the fine print: the discounted price has historically depended on refilling within a set window, so letting a month lapse can reset what you pay (⚠ verify current refill-window rule).

The trade-offs are real but manageable. Vials mean handling syringes rather than an auto-injector. Not every strength has been available in every format (⚠ verify which doses the vials cover). And cash payments through LillyDirect generally don’t count toward an insurance deductible.

Still — for the uninsured, and for everyone whose employer plan excludes weight-loss drugs, this is usually the cheapest legitimate way to take brand-name Zepbound. Run the comparison once and it’s not close: ~$1,086 at a retail counter, roughly $650 with the savings card on a commercial plan that won’t cover it, and $349–$499 direct from Lilly.

Zepbound cost with insurance

Commercial insurance splits into three camps: plans that cover Zepbound, plans that cover it behind hoops, and plans that exclude weight-loss medication entirely. That last camp is bigger than most people expect — the exclusion is a choice your employer made when it built the plan, not a judgment about you or the drug. If the plan documents say “weight-loss drugs not covered,” no amount of paperwork changes it (though the sleep-apnea pathway below can be a separate door).

Even when Zepbound is covered, expect prior authorization: your prescriber documents your BMI, any weight-related conditions, and sometimes months of “lifestyle intervention” first. Some plans add step therapy — try a cheaper drug before this one. It’s tedious, but it’s routine tedium; clinics that prescribe GLP-1s file these constantly.

Once approved, copays typically land between $25 and $650 a month — $25 when the savings card stacks on decent coverage, more when your plan’s tier placement is stingy.

If you’re denied, appeal. The denial letter must state a reason, and the counter-move is a letter of medical necessity from your prescriber addressing that exact reason — the BMI documentation, the weight-related conditions, the treatments already tried. Plans overturn a meaningful share of appeals, and if the internal appeal fails you’re entitled to an external review by an independent third party. Persistence is genuinely a pricing strategy here.

One more wrinkle worth checking before you assume the worst: coverage can change at plan renewal. Employers add and drop weight-loss drug coverage year to year, and a “no” in January is sometimes a “yes” after open enrollment. If Zepbound matters to you, it’s a fair thing to raise with HR — benefits teams do track those requests.

Does Medicare cover Zepbound?

For years the flat answer was no — Medicare Part D was barred by statute from covering drugs prescribed for weight loss. Two things have cracked that open:

• The sleep apnea indication. Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity, and that’s a medical indication Part D plans can cover. In practice this means Zepbound may be covered for a Medicare patient with diagnosed OSA even where weight-loss coverage is excluded — the indication on the prescription is what matters, and whether it applies to you is your prescriber’s call, not a box you elect to tick (⚠ verify plan-level handling of the OSA pathway).
• The 2026 coverage expansion. Beginning in 2026, eligible Part D plans cover Zepbound with copays around $50 a month (⚠ verify — which plans participate, eligibility criteria, and the exact copay are still settling as the expansion rolls out).

Two cautions. Coverage is plan-by-plan even within Medicare, so check your specific plan’s formulary. And the Zepbound savings card never applies to Medicare, Medicaid, TRICARE, or any other government plan — that’s federal anti-kickback law, not Lilly policy.

Medicaid coverage of weight-loss drugs varies state by state; a handful cover GLP-1s for weight management, most don’t.

How to pay less for Zepbound

The realistic levers, in rough order of impact:

1. The savings card — read the fine print. It requires commercial (employer or marketplace) insurance; government plans are ineligible, full stop. If your plan covers Zepbound, the card drops your copay to as low as $25/mo. If you have commercial insurance that doesn’t cover it, the card has historically still knocked the price down to around $650/mo (⚠ verify the current not-covered price and the card’s monthly/annual caps). Enrollment is free at Lilly’s savings page — there is no legitimate paid version of this card.
2. Lilly’s self-pay program. The ~$349–$499 LillyDirect route above. For anyone without coverage, this beats the not-covered savings-card price by hundreds a month.
3. The sleep-apnea pathway. If you have diagnosed OSA, coverage may run through that indication even on plans that exclude weight-loss drugs. Raise it with your prescriber — it’s their determination to make.
4. FSA/HSA dollars. Prescription medications are qualified expenses, so you can usually pay copays or self-pay costs with pre-tax money. That’s an effective 20–35% discount depending on your tax bracket (⚠ verify framing).
5. Don’t wait for a generic. There isn’t one, and there won’t be for years — anything marketed as “generic Zepbound” or “generic tirzepatide” is a scam signal, not a deal.
6. Compounded tirzepatide — know the grey zone. During the shortage, compounding pharmacies legally sold cheaper tirzepatide copies. The FDA has since declared the shortage over, which ended the legal basis for mass-compounded versions; what remains floats in a murkier space (⚠ verify current enforcement status). We cover that landscape informationally in the tirzepatide guide — it’s a thing to understand, not a recommendation.

One last variable worth knowing: on the self-pay route, your dose sets your price, since vial tiers step up with strength. Where you land on the titration ladder — and whether you maintain at 5, 10, or 15 mg — has a direct line to your monthly bill. The Zepbound dosage guide walks that ladder.